Profil
Steve Colletti is currently the Chief Scientific Officer at Korro Bio, Inc. He previously worked as the SVP-Drug Discovery Research & Development at Zymergen, Inc. from 2021 to 2023.
Before that, he was the Chief Scientific Officer at Lodo Therapeutics Corp.
from 2018 to 2021.
Dr. Colletti holds a doctorate degree from Boston University and an undergraduate degree from Loyola University of Chicago.
Postes actifs de Steve Colletti
| Sociétés | Poste | Début |
|---|---|---|
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Directeur Technique/Scientifique/R&D | 01/02/2023 |
Anciens postes connus de Steve Colletti
| Sociétés | Poste | Fin |
|---|---|---|
| ZYMERGEN INC. | Corporate Officer/Principal | 01/01/2023 |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Directeur Technique/Scientifique/R&D | 01/05/2021 |
Formation de Steve Colletti
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Loyola University of Chicago
Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Zymergen, Inc.
Zymergen, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that designs and develops genomics products | Health Technology |
Lodo Therapeutics Corp.
Lodo Therapeutics Corp. BiotechnologyHealth Technology Discovers and develops novel therapeutics | Health Technology |
Korro Bio, Inc.
Korro Bio, Inc. BiotechnologyHealth Technology Develops novel genetic medicines | Health Technology |
















